Records 1 - 4
| Identification of NOTCH4 mutation as a response biomarker for immune checkpoint inhibitor therapy.
BMC medicine 2021 Jul 19 (1): 154.
Long Junyu, Wang Dongxu, Yang Xu, Wang Anqiang, Lin Yu, Zheng Mingjun, Zhang Haohai, Sang Xinting, Wang Hanping, Hu Ke, Zhao Hait
| Comprehensive genomic profile of Chinese lung cancer patients and mutation characteristics of individuals resistant to icotinib/gefitinib.
Scientific reports 2020 Nov 10 (1): 20243.
Shang Yanhong, Li Xiaofang, Liu Weiwei, Shi Xiaoliang, Yuan Shaohua, Huo Ran, Fang Guotao, Han Xiao, Zhang Jingnan, Wang Kunjie, Dou Zhengyue, Zhang Yan, Zang Aimin, Zhang L
| Association between single nucleotide polymorphisms of NOTCH signaling pathway-related genes and the prognosis of NSCLC.
Cancer management and research 2019 11 6895-6905.
Xu Qiuping, Lin Danhua, Li Xu, Xiao Rendong, Liu Zhiqiang, Xiong Weimin, Cai Lin, He F
| [Association between polymorphism in notch signaling pathway and lung cancer risk].
Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine] 2018 Mar 52 (3): 243-252.
Xu Q P, Xiao R D, Xiong W M, He F, Cai